SCI Pharmtech Inc Cash Flow Quality Index
SCI Pharmtech Inc cash flow quality index. SCI Pharmtech Inc (4119) has a Cash Flow Quality Index of 1.83x as of March 2026. Operating cash flow of NT$36.89 Million exceeds net income of NT$20.11 Million, indicating high earnings quality where cash backs reported profits. Explore SCI Pharmtech Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of SCI Pharmtech Inc (2002–2025)
Cash flow quality index of SCI Pharmtech Inc from 2002 to 2025. Historical Cash Flow Quality Index for SCI Pharmtech Inc across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. See SCI Pharmtech Inc net asset quality index to measure how much of total assets are equity-financed.
SCI Pharmtech Inc Cash Flow Quality Index by Year (2002–2025)
SCI Pharmtech Inc cash flow quality index by year from 2002 to 2025. Year-by-year earnings quality comparison for SCI Pharmtech Inc. For the full cash flow conversion analysis, see 4119 cash flow metrics.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.05x | NT$220.32 Million | NT$107.37 Million | ▲ +54.2% |
| 2024 | 1.33x | NT$860.52 Million | NT$646.86 Million | ▲ +124.5% |
| 2023 | 0.59x | NT$215.77 Million | NT$364.19 Million | ▼ -22.5% |
| 2022 | 0.76x | NT$296.56 Million | NT$387.82 Million | ▼ -82.1% |
| 2021 | 4.28x | NT$280.28 Million | NT$65.51 Million | ▲ +100.5% |
| 2020 | 2.13x | NT$971.53 Million | NT$455.21 Million | ▲ +91.7% |
| 2019 | 1.11x | NT$791.60 Million | NT$711.16 Million | ▲ +26.3% |
| 2018 | 0.88x | NT$480.18 Million | NT$544.79 Million | ▼ -26.5% |
| 2017 | 1.20x | NT$281.65 Million | NT$234.77 Million | ▲ +20.8% |
| 2016 | 0.99x | NT$502.11 Million | NT$505.70 Million | ▼ -32.4% |
| 2015 | 1.47x | NT$663.24 Million | NT$451.49 Million | ▲ +37.2% |
| 2014 | 1.07x | NT$358.77 Million | NT$335.09 Million | ▼ -13.0% |
| 2013 | 1.23x | NT$238.57 Million | NT$193.78 Million | ▼ -37.9% |
| 2012 | 1.98x | NT$385.57 Million | NT$194.45 Million | ▼ -28.5% |
| 2011 | 2.77x | NT$249.55 Million | NT$90.02 Million | ▲ +116.8% |
| 2010 | 1.28x | NT$218.96 Million | NT$171.24 Million | ▼ -32.9% |
| 2009 | 1.91x | NT$316.96 Million | NT$166.31 Million | ▲ +21.7% |
| 2008 | 1.57x | NT$245.29 Million | NT$156.60 Million | ▲ +40.7% |
| 2007 | 1.11x | NT$167.53 Million | NT$150.51 Million | ▼ -61.1% |
| 2006 | 2.86x | NT$131.62 Million | NT$45.98 Million | ▲ +56.1% |
| 2004 | 1.83x | NT$76.61 Million | NT$41.78 Million | ▼ -22.7% |
| 2003 | 2.37x | NT$206.86 Million | NT$87.19 Million | ▲ +84.8% |
| 2002 | 1.28x | NT$107.12 Million | NT$83.44 Million | — |